BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+46.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.07B
AUM Growth
+$7.07B
(+37%)
Cap. Flow
+$60.6M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
231
New
17
Increased
84
Reduced
52
Closed
23
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$38.5M |
| 2 |
Generation Bio
GBIO
|
$30.2M |
| 3 |
Stryker
SYK
|
$27.2M |
| 4 |
Insulet
PODD
|
$25.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
$23.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.3M |
| 2 |
Moderna
MRNA
|
$38.9M |
| 3 |
Illumina
ILMN
|
$38.1M |
| 4 |
Intuitive Surgical
ISRG
|
$36.5M |
| 5 |
MacroGenics
MGNX
|
$31.2M |
Sector Composition
| 1 | Healthcare | 96.05% |
| 2 | Industrials | 0.58% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.29% |
| 5 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Zymeworks
ZYME
$1.12B
| – | – |
-18,400
| Closed | -$653K |
|
|
SYNH
227
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-61,900
| Closed | -$2.44M |
|
|
CLVS
228
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-71,200
| Closed | -$453K |
|
|
XLRN
229
DELISTED
Acceleron Pharma Inc.
XLRN
| – | – |
-21,700
| Closed | -$1.95M |
|
|
CBPO
230
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| – | – |
-4,500
| Closed | -$486K |
|
|
BHVN
231
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-24,800
| Closed | -$844K |
|